AI assistant
Sending…
Jade Biosciences, Inc. — Director's Dealing 2021
Jun 30, 2021
33383_dirs_2021-06-29_7189f6fa-ad84-4757-825c-b369ed339e92.zip
Director's Dealing
Open in viewerOpens in your device viewer
SEC Form 3 — Initial Statement of Beneficial Ownership
Issuer: Aerovate Therapeutics, Inc. (AVTE)
CIK: 0001798749
Period of Report: 2021-06-29
Reporting Person: Resnick Joshua (Director)
More from Jade Biosciences, Inc.
Regulatory Filings
2026
Jun 1
Regulatory Filings
2026
May 15
Regulatory Filings
2026
May 7
Regulatory Filings
2026
May 7
Regulatory Filings
2026
May 7
Regulatory Filings
2026
May 7
Regulatory Filings
2026
Apr 22
Major Shareholding Notification
2026
Feb 17
Major Shareholding Notification
2026
Feb 17
Major Shareholding Notification
2026
Feb 17